Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics (NASDAQ:MYGN), a molecular diagnostic testing and precision medicine company, announced its participation in two upcoming healthcare investor conferences. Management will present at the Wells Fargo Healthcare Conference on September 4, 2025, at 3:45 PM ET and the Morgan Stanley Annual Global Healthcare Conference on September 10, 2025, at 7:45 AM ET. Both presentations will be available via webcast on the company's investor relations website.
Myriad Genetics (NASDAQ:MYGN), società attiva nella diagnostica molecolare e nella medicina di precisione, ha annunciato la partecipazione a due prossimi convegni per investitori nel settore sanitario. Il management presenterà al Wells Fargo Healthcare Conference il 4 settembre 2025 alle 15:45 ET e al Morgan Stanley Annual Global Healthcare Conference il 10 settembre 2025 alle 07:45 ET. Entrambe le presentazioni saranno disponibili in webcast sul sito web delle relazioni con gli investitori della società.
Myriad Genetics (NASDAQ:MYGN), una compañía de diagnóstico molecular y medicina de precisión, anunció su participación en dos próximas conferencias para inversores del sector sanitario. La dirección presentará en el Wells Fargo Healthcare Conference el 4 de septiembre de 2025 a las 15:45 ET y en el Morgan Stanley Annual Global Healthcare Conference el 10 de septiembre de 2025 a las 07:45 ET. Ambas presentaciones estarán disponibles vía webcast en la web de relaciones con inversores de la compañía.
Myriad Genetics (NASDAQ:MYGN)는 분자 진단 및 정밀 의학 회사로, 다가오는 두 건의 헬스케어 투자자 컨퍼런스에 참여한다고 발표했습니다. 경영진은 Wells Fargo Healthcare Conference에서 2025년 9월 4일 동부시간(ET) 오후 3시 45분에 발표하며, Morgan Stanley Annual Global Healthcare Conference에서는 2025년 9월 10일 동부시간(ET) 오전 7시 45분에 발표합니다. 두 발표 모두 회사 투자자 관계 웹사이트를 통해 웹캐스트로 시청할 수 있습니다.
Myriad Genetics (NASDAQ:MYGN), société spécialisée en diagnostics moléculaires et médecine de précision, a annoncé sa participation à deux prochaines conférences pour investisseurs dans le domaine de la santé. La direction présentera au Wells Fargo Healthcare Conference le 4 septembre 2025 à 15h45 ET et au Morgan Stanley Annual Global Healthcare Conference le 10 septembre 2025 à 07h45 ET. Les deux présentations seront disponibles en webcast sur le site relations investisseurs de la société.
Myriad Genetics (NASDAQ:MYGN), ein Unternehmen für molekulare Diagnostik und Präzisionsmedizin, gab seine Teilnahme an zwei bevorstehenden Healthcare-Investorenkonferenzen bekannt. Das Management wird am Wells Fargo Healthcare Conference am 4. September 2025 um 15:45 Uhr ET und am Morgan Stanley Annual Global Healthcare Conference am 10. September 2025 um 07:45 Uhr ET präsentieren. Beide Präsentationen werden per Webcast auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.
- The Wells Fargo Healthcare Conference with a fireside chat on Thursday, Sept. 4 at 3:45pm ET.
- The Morgan Stanley Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 10 at 7:45am ET.
Links to the live and archived webcasts of both presentations can be viewed at investor.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com
FAQ
When is Myriad Genetics (MYGN) presenting at the Wells Fargo Healthcare Conference 2025?
What time is Myriad Genetics presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Myriad Genetics' (MYGN) conference presentations?
Which investor conferences is Myriad Genetics (MYGN) attending in September 2025?
